Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb;271(2):211-23.
doi: 10.1007/s00405-013-2400-9. Epub 2013 Mar 7.

Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications

Jennifer L Hunt  1 , Leon Barnes, James S Lewis Jr, Magdy E Mahfouz, Pieter J Slootweg, Lester D R Thompson, Antonio Cardesa, Kenneth O Devaney, Douglas R Gnepp, William H Westra, Juan P Rodrigo, Julia A Woolgar, Alessandra Rinaldo, Asterios Triantafyllou, Robert P Takes, Alfio Ferlito
Affiliations
Review

Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications

Jennifer L Hunt et al. Eur Arch Otorhinolaryngol. 2014 Feb.

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a common malignancy that continues to be difficult to treat and cure. In many organ systems and tumor types, there have been significant advances in the understanding of the molecular basis for tumorigenesis, disease progression and genetic implications for therapeutics. Although tumorigenesis pathways and the molecular etiologies of HNSCC have been extensively studied, there are still very few diagnostic clinical applications used in practice today. This review discusses current clinically applicable molecular markers, including viral detection of Epstein-Barr virus and human papillomavirus, and molecular targets that are used in diagnosis and management of HNSCC. The common oncogenes EGFR, RAS, CCND1, BRAF, and PIK3CA and tumor suppressor genes p53, CDKN2A and NOTCH are discussed for their associations with HNSCC. Discussion of markers with potential future applications is also included, with a focus on molecular alterations associated with targeted therapy resistance.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Natl Cancer Inst. 2008 Feb 20;100(4):261-9 - PubMed
    1. Oral Oncol. 2011 Jun;47(6):487-96 - PubMed
    1. Clin Cancer Res. 2000 Aug;6(8):3177-82 - PubMed
    1. Am J Surg Pathol. 2008 Jul;32(7):1044-50 - PubMed
    1. Oral Oncol. 2012 Nov;48(11):1114-9 - PubMed

MeSH terms

LinkOut - more resources